Uncertainty about the phase of strings of SNPs creates complications in genetic analysis, although methods have been developed for phasing population-based samples. However, these methods can only phase a small number of SNPs effectively and become unreliable when applied to SNPs spanning many linkage disequilibrium (LD) blocks. Here we show how to phase more than 1,000 SNPs simultaneously for a large fraction of the 35,528 Icelanders genotyped by Illumina chips. Moreover, haplotypes that are identical by descent (IBD) between close and distant relatives, for example, those separated by ten meioses or more, can often be reliably detected. This method is particularly powerful in studies of the inheritance of recurrent mutations and fine-scale recombinations in large sample sets. A further extension of the method allows us to impute long haplotypes for individuals who are not genotyped.
Uncertainty about the phase of strings of SNPs creates complications in genetic analysis, although methods have been developed for phasing population-based samples. However, these methods can only phase a small number of SNPs effectively and become unreliable when applied to SNPs spanning many linkage disequilibrium (LD) blocks. Here we show how to phase more than 1,000 SNPs simultaneously for a large fraction of the 35,528 Icelanders genotyped by Illumina chips. Moreover, haplotypes that are identical by descent (IBD) between close and distant relatives, for example, those separated by ten meioses or more, can often be reliably detected. This method is particularly powerful in studies of the inheritance of recurrent mutations and fine-scale recombinations in large sample sets. A further extension of the method allows us to impute long haplotypes for individuals who are not genotyped.
The availability of high-density SNP arrays has revolutionized genetic studies. However, genotypes of SNPs from these arrays are not phased. For many genetic analyses, it would be empowering if the uncertainty about phase could be eliminated. Many statistical methods have been proposed to phase SNPs for a set of individuals sampled from a population [1] [2] [3] [4] [5] . These methods, which we call local phasing, exploit strong correlations of SNP alleles within LD blocks. Some can be very slow computationally, but the main limitation of these methods is that SNPs that are separated by many LD blocks cannot be reliably phased.
Family data provide a simple way to phasing. When both parents of the proband are genotyped, SNPs that are not triply heterozygous, that is, heterozygous for both parents and child, can be phased. The method presented here, which we call long-range phasing (LRP), is based on the same principle as phasing with family data, but we can often perform the task even when the parents are not genotyped. When the parents are genotyped, our method can phase many of the SNPs that are triply heterozygous.
To understand the method, some knowledge about the Icelandic population is necessary. A genealogy database constructed by deCode includes 740,033 individuals, with 410,551 born at or after 1900 and about 316,000 now living. In particular, the part of the genealogy after 1650 is rather complete and accurate. Using the latter to perform simulations, we studied the population characteristics of IBD sharing among the 35,528 Icelanders we had genotyped using Illumina chips. For a random proband in this set and for a particular genomic locus, there are on average 17.6 and 18.1 (for her paternal and maternal chromosome, respectively) other individuals in the genotyped set who have inherited the locus IBD ( Table 1) . This means that the average kinship coefficient between the genotyped individuals is approximately (17.6 + 18.1)/(4 Â 35,528) B 2.5 Â 10 À4 . This is not particularly high, as Icelanders are not inbred, but is nonetheless high enough that a substantial number of the genotyped people are expected to share a region IBD. This has important implications. Consider two individuals who are nth-degree cousins separated by 2 Â (n + 1) meioses. Their chance of sharing a locus IBD is 2 -2n . This chance is small if n is larger than 2 or 3, but given that they do share a locus IBD, they are expected to share a region on average 200/(2n + 2) centiMorgans (cM) in genetic length. If n is 9, the shared region is on average 10 cM in width. Given data for about 300,000 SNPs, they would share a haplotype that on average includes about 1,000 SNPs. When two people share a haplotype, for each SNP making up the haplotype, they would have at least one allele identical by state (IBS), and IBS Z 1 for 1,000 or more SNPs consecutively would usually be above the noise level. For more closely related individuals, the expected width of the shared region is larger and even easier to detect. Once a relative is shown to share a region IBD with the proband, she can be used to phase the proband just like a parent; the relative functions as a surrogate father if she carries the paternal haplotype of the proband, and a surrogate mother if she carries the maternal haplotype of the proband (Fig. 1) . Note, however, that (i) a surrogate father (mother) is not necessarily male (female), (ii) there can be multiple surrogate fathers and surrogate mothers and (iii) for the same proband, the surrogate fathers and mothers change from locus to locus. The phase of a heterozygous SNP in the proband is determined if any of the parents, real or surrogate, is homozygous. Moreover, note that surrogate parenthood is a nondirectional relationship; that is, if B is a surrogate parent of A, then A is a surrogate parent of B. Also, if B and C are, respectively, a surrogate father and surrogate mother of A, B can assist the phasing of C through the phasing of A even though B and C do not share a haplotype. The key concepts are best captured by a graph in which the nodes correspond to typed individuals and edges are put between pairs who are surrogate parents of each other. Two individuals are surrogate relatives if they are connected, directly or indirectly, with respect to this haplotype-sharing graph, and the distance between them is the length of the shortest path linking them. We refer to this as the Erdös distance, as it is a clear analog to the Erdös number defined for co-authorships 6 . Thus, surrogate parents are surrogate relatives with Erdös distance 1. Surrogate relatives with Erdös distance 2 or above by definition do not share a haplotype at the locus and hence may not be related at all. However, what gives LRP extraordinary power is that a SNP that is heterozygous in the proband can be phased if one of the surrogate relatives, regardless of Erdös distance, is homozygous (Methods). With our data, many of the typed individuals have more than 30,000 surrogate relatives, including some who have only one surrogate parent, and often every SNP can be phased. Some useful applications of the method are presented below.
RESULTS

Phasing
Our first target was a 10-Mb region on chromosome 6 (NCBI Build 36: 26.5 Mb to 36.5 Mb) that includes the MHC region (B29.7-33.3 Mb). We used a total of 2,187 SNPs, a subset of 290,449 SNPs in the genome that satisfies various quality and yield criteria (Methods) and that covers an extended region of approximately 15 Mb (24.3-39.1 Mb), for phasing the 1,469 SNPs in the target region. Genetically, the target region is approximately 6 cM (ref. 7) and the extended region is approximately 10 cM.
Applying LRP in a simple and conservative manner, that is, considering only individuals who share IBS Z 1 for the entire extended region with a proband as potential surrogate parents, we found that 1,995 (5.6%) of the 35,528 typed individuals were not phased at all either because no surrogate parents were identified for them initially or because putative surrogate parents identified were eliminated later in the phasing process as a result of incompatibilities (Methods). Among the others, 30,954 (87.1% of the total) were phased for every SNP, and 2,579 (7.3%) were phased for 90.4% of the heterozygous genotypes ( Table 2) . Overall, counting all 35,528 individuals, the proportion of heterozygous SNPs phased (yield) was 93.7% (16, 201 ,012 out of 17,287,391). There were 2,839 fathermother-offspring trios among the typed individuals. To empirically evaluate the accuracy of our phasing method, we removed the parents (3,826 individuals) in these trios from the list of typed individuals. Because some of the removed parents were themselves offspring in typed trios, 2,718 offspring were left. We phased these 2,718 offspring probands by applying LRP to the reduced list of 31,702 individuals, and we then compared the results to those from phasing the offspring using data from their parents only. From LRP on the reduced group, 200 (7.4%) individuals could not be phased. Among the remaining individuals, 2,299 were phased for all SNPs, and 219 were partially phased (yield ¼ 84.5%). The overall yield including the unphased individuals was 91.4%. From phasing based on parental data, all probands were partially phased, with a yield of 80.6%. Among the 978,802 heterozygous genotypes phased by both methods, there were 845 (0.086%) discrepancies (Supplementary Table 1 online). Individually, there were no discrepancies between LRP and trio phasing results for 2,456 (97.5%) of the 2,518 offspring phased by LRP. Among the 62 probands with discrepancies, 43 had a discrepancy for only a single SNP. Considering that nearly one million phased genotypes were compared, many of these discrepancies could be attributed to miscalled genotypes in the parents (that is, the LRP result could often be correct). Ten offspring had more than three discrepancies. Three of these ten are siblings, and they account for over 50% (468/845) of the total genotype discrepancies. One sib has IBS Z 1 with each of the other two sibs, who share both haplotypes in this region, but the sharing does not result from sharing one haplotype for the entire target region, but rather sharing the paternal haplotype for part of the region and the maternal haplotype for another part, with overlap. This complication contributed directly to the phasing mistake and we expect that future adjustments to the algorithm will reduce such errors (Supplementary Note online). Figure 1 The concept of surrogate parenthood. Typed relatives who share either the paternal or maternal haplotypes of the proband can be used to phase the proband as though they are actual parents. These relatives are referred to as surrogate fathers and surrogate mothers, respectively. A surrogate father does not have to be a male and a surrogate mother does not have to be a female. Surrogate parenthood is locus specific. A sibling can be a surrogate father for one locus and a surrogate mother for another locus. However, for a locus where the sibling shares both haplotypes with the proband, the sibling is like a twin and cannot be used to phase the proband.
The phased MHC region has a lower recombination rate than the genome-wide average, whereas the density of typed SNPs is substantially higher than average. We applied the same phasing algorithm to a location on 15q25 where the recombination rate is approximately 1 cM/Mb and where we have about 90 typed SNPs per Mb, both close to the genome average. We considered two regions, one longer (B10.0 Mb, 895 SNPs) and one shorter (B6.4 Mb, 574 SNPs) (Supplementary Note). For the longer region, the results matched those of the MHC closely, with an overall yield of 93.5% for the run with 35,528 individuals and a discrepancy rate of 0.080% in the trio test. Results for the shorter region were better, with an overall yield of 95.2% and a discrepancy rate of 0.022% ( To further understand the workings of LRP, we randomly ordered the 35,528 typed individuals, and removed 50 of them at a time from the haplotype-sharing graph. Every time individuals were removed, we recomputed the fraction of individuals who had at least one surrogate parent ( Fig. 2a) and the fraction of individuals belonging to the main (largest connected) cluster in the haplotype-sharing graph (Fig. 2b) . The results were similar for the MHC region and the 10-Mb 15q25 region, and higher for the 15q25 6.4-Mb region. Specifically, with as little as 2% of the Icelandic living population (B6,300) typed, for the MHC and the 10-Mb 15q25 regions, about 78% of the individuals would have at least one surrogate parent and about 59% of the individuals belong to the main cluster. We achieved similar results for the shorter 6.4-Mb 15q25 region by genotyping about 1.5% (B4,700) of the living population. With improved analytical tools (see below) and, in some cases, by focusing on smaller regions, useful results could possibly be obtained with only 1% of the living population genotyped. On the basis of the fraction of the population typed, we believe that these results would apply, albeit crudely, to populations of various sizes, including large outbred populations (see the Supplementary Note for a discussion of how LRP might work with non-Icelandic data).
The yield of LRP presented here is high, but it would likely be even higher if not for the current algorithm, which is a first attempt at implementing a procedure that can process data in mass and give reliable results, and is both conservative and inefficient. Much information is not used, and we expect that by incorporating a number of refinements (Supplementary Note) to the procedure, the yield would increase without elevating the error rate. At present, yield is limited by the criterion that an individual is considered a surrogate parent only if Yield refers to the proportion of heterozygous SNPs phased. 
she is IBS Z 1 with the proband for the entire extended region. This could not only rule out true surrogate parents owing to a single genotyping error, but also eliminate individuals who share a very long haplotype with the proband, part of it extending beyond the extended region on one side but not covering the entire target or extended region. Using these individuals in a proper manner is crucial to our ultimate goal of phasing chromosomes in their entirety, achievable by stitching together phasing results from overlapping target regions. We compared LRP with PHASE 2 and fastPHASE 5 . However, PHASE is too slow for meaningful comparisons. For the shorter 15q25 region, with the parents in the 2,718 trios removed, fastPHASE and LRP processed 31,702 typed individuals in 260 h and 90 min, respectively. Based on the trio test, the discrepancy rate was 30.58% for fastPHASE and 0.022% for LRP. For the individuals and SNPs it can phase, we estimate that LPR can phase a region 1,000 times longer than fastPHASE with a similar probability of not making any errors (Supplementary Note and Supplementary Table 3 online). These results reinforce the point that local phasing methods are not designed to phase long regions on their own. However, improvements to LRP could be achieved by incorporating local phasing ideas (Supplementary Note).
Studying fine-scale recombination
There is much interest in recombination hot spots and their evolution [8] [9] [10] . Apart from methods that estimate historic recombination rates on the basis of LD patterns, a recent study has investigated recombination events directly by utilizing high-density SNP data from 725 related individuals falling into 82 nuclear families 11 . A number of interesting observations were made, even though there was only information on 728 meioses.
The main difficulty with studying recombination events in chromosomes transmitted to the children is that the parents need to be phased. But phasing the parents directly requires genotyping the grandparents, a serious limiting factor. An alternative is to utilize nuclear families with three or more children genotyped. Here, in effect, the children are used to phase the parents. Specifically, if both parents and two children are genotyped, one can detect a recombination event, but it would be impossible to tell in which child the event occurred. With more than two children, by assuming that the chance that more than one child has gone through a recombination event in a small region is negligible, the uncertainty in phase is resolved by the majority rule. Figure 3 shows an example of a recombination observed at a known hot spot in the MHC region. The recombination event between SNPs rs2532924 and rs3095089 (SNP5 and SNP6) could be deduced from data on the two parents and the three children (C1 to C3). It is clear that all three children share the maternal allele IBD for rs2532924. As C1 and C2 also share the maternal allele for rs3095089 IBD, but C3 does not, one can deduce that a recombination event occurred between the two SNPs for the maternal meiosis of C3. If the data for C1 were not available, one could still deduce that a recombination event occurred in either C2 or C3, but assigning it to a specific child would not be possible. If neither C1 nor C2 were genotyped, the recombination event could not be inferred using traditional approaches without genotyping the maternal grandparents.
By applying LRP, we were able to phase the mother using data on her more distant relatives. This phasing information, together with the data on the father and C3 alone, allowed us to infer the same recombination event that was deduced by also using the data of C1 and C2. As detailed in the figure legend (Fig. 3) , having genotypes of relatives R2 to R4 could actually provide better resolution of the recombination event than having the genotypes of the parents of M. As noted earlier, a substantial fraction of the heterozygous SNPs in M could remain unphased even with data on parents, but having data on a large number of surrogate parents and surrogate relatives could enable every SNP to be phased. Also worth noting is that a sibling of M, SM, is genotyped, but because he shares both haplotypes with M he is actually not useful for phasing M at this locus. By contrast, R2 and R4, the key individuals, are separated from M by seven meioses and hence not close relatives. Figure 3 Applying long-range phasing to determine a recombination event. The results from phasing a 10-Mb region including the MHC were used, although only the 10 SNPs around the recombination event are highlighted. By phasing M using relatives R1 to R4, the recombination event in C3 could be deduced on the basis of data from the trio F, M and C3 only, without the need of data from C1 and C2 or from the parents of M. Having R2 and R4 could actually be better than having the two parents of M. A SNP informative for recombination in the children has to be heterozygous in M; here, both SNP5 and SNP6 are. To phase M, one of her parents (if typed) or surrogate relatives needs to be homozygous. In this case, R2 and R4 are each homozygous for both SNP5 and SNP6, so having one of them would be sufficient to deduce the precise location of the recombination. By contrast, R1 is homozygous at SNP6 but heterozygous at SNP5. With R1 only, we could deduce that a recombination in C3 occurred between SNP3 (the closest marker on the left that is heterozygous for M and homozygous for R1) and SNP6, but some resolution would be lost. The same could happen if one or both parents of M were typed. Surrogate relatives who are not surrogate parents of M can also help (for example, the uncertain phase of SNP 5 in R1 can be resolved by surrogate parents of his sharing the other haplotype). Surrogate parents of R1 are surrogate relatives of M with Erdös distance 2.
By phasing the parents with LRP, we can estimate recombination events from trio data. In addition to 194 nuclear families with both parents and three or more children genotyped, the 35,528 chip-typed individuals include 1,257 and 475 nuclear families with one and two children genotyped, respectively. The latter families alone could provide up to 4,414 ¼ 2 Â (1,257 + 2 Â 475) meioses for the study of fine-scale recombination.
Studying the inheritance of a recurrent deletion Recent studies support the notion that recurrent structural mutations may contribute substantially to the risks of psychiatric disorders such as autism 12 and schizophrenia 13 . Recently, we found evidence suggesting that a recurrent deletion at 15q11.2 is associated with schizophrenia 14 . Assuming that the association is real, the penetrance is not very high. In Iceland, a total of 63 carriers were observed: 4 in 646 schizophrenics, one in a parent of a schizophrenic, and 58 in 32,442 controls (OR B3.5). Here we explore the inheritance of this deletion independent of its putative association with schizophrenia. Out of the 63 chromosomes with the deletion, 14 of the parents of origin were chip-typed. Twelve of these 14 parents also carry the deletion (part of the 63) and one does not; the latter points to a de novo event for the proband. Given that many of the deletion carriers do not have a 'firstgeneration' de novo mutation, we investigated the relationship between the 63 chromosomes with the deletion through long-range phasing. The deletion resides in a difficult region. Chromosome 15 has a very short p arm. Among the SNPs used, only two are on the left of the deletion (51 are inside), meaning that the information in determining whether two chromosomes are IBD comes mostly from SNPs on the right side. This region also has a high recombination rate, so that fewer SNPs than average are included for a specific genetic distance. Nonetheless, substantial progress was made (Fig. 4) . Probands 1 and 2 (P1 and P2) carry the deletion IBD (sharing a haplotype B1,500 SNPs in length not including the 51 SNPs in the deleted region). Relatives 1 to 3 (R1, R2 and R3) also share a long haplotype with the probands (over 4,000 SNPs with P1 and B1,500 SNPs with P2), but they do not have the deletion. One can deduce from the family relationship that the grandfather (GF) has the deletion, and the mutation event occurred either at the meiosis of GF or GGM. By phasing R1 to R3, we could reconstruct the haplotype of the 51 SNPs that were deleted in P1 and P2 together with the haplotype background of over 4,000 SNPs.
Overall, by studying the haplotype backgrounds, we deduced that the 63 deletions correspond to approximately 31 separate mutation or deletion events (Supplementary Note). A rather complex pattern of inheritance was indicated. First, carriers of these deletions are not completely infertile and, moreover, could pass on the deletion to their children (one carrier with 5 children in total passed on the deletion to all 4 of the chip-typed children). However, the probability that the carriers could pass on the deletion to a child seems to be substantially less than that under a model of neutrality. The many haplotype backgrounds observed for the chromosomes with the deletion indicate that the deletion occurs rather frequently as a de novo event. This is in sharp contrast to other rare variants such as the BRCA2 999del5 (NM_000059) mutation in Iceland, where all chromosomes with the mutation seem to have a single founder and share a haplotype background 15, 16 . If the deletions were inherited neutrally, they would be expected to have a much higher frequency in the population than observed. Hence, this analysis provides support for the notion that the deletions are under negative selection, but statistical methods still need to be developed to test for negative selection formally and to estimate its magnitude.
Imputing haplotypes into untyped individuals
In Figure 4 , it can be inferred that individuals GGM and GF, who are not genotyped, both carry the haplotype shared by R1/2/3 and P1/2. In general, a haplotype can be imputed into an untyped proband if two genotyped relatives share a long haplotype IBD and the genealogy indicates that the path of IBD sharing goes through the proband. There are three standard conditions to ensure this. First, one of the chip-typed relatives should be a descendant, preferably a child or a grandchild. Second, with some exceptions (discussed in point 3), the other chip-typed relative should not be a descendant. Unless the mate of the proband is chip-typed, this relative is preferably substantially more closely related to the proband than the mate. Third, the other genotyped relative could also be a descendant if either the mate of the proband is genotyped or the two chip-typed descendants are from different mates (for example, half-sibs).
The first condition is required because one can only reliably deduce that an untyped proband carries a haplotype if a descendant has inherited it. The second and third conditions ensure that the chance that the shared haplotype was transmitted to the descendant through the mate instead of the proband is small. If the descendant is a grandchild, in addition to data ruling out transmission from the mate of the proband, data are needed to show that the sharing of the haplotype did not go through the other two grandparents instead.
The first condition is often the limiting factor. As indicated in Table 1 , for untyped probands, the average number of chip-typed relatives expected to share the paternal or maternal chromosome IBD exceeds 15 each. By contrast, for the untyped probands born at or after 1900, the expected number of typed descendants carrying the paternal Where the de novo deletion is likely to have occurred Figure 4 The inheritance of a chromosome associated with a deletion. Typed are P1/2 and R1/2/3. Long-range phasing revealed that they all share a haplotype with over 1,000 SNPs, although only P1 and P2 carry the deletion. Shown are alleles of every third SNP of the first 100 SNPs on chromosome 15, including 17 of the 51 SNPs deleted. It can be inferred from the family structure that the shared region was transmitted to P1 and P2 through GGM and GF. Note that with only two typed SNPs (one shown) on the left of the deletion, the first two SNPs might only be IBS and not IBD between R1/2/3 and P1/2, as it could not be ruled out that a recombination event close by had taken place at one of the intermediary meioses, particularly as it is known that a recombination often accompanies a deletion event 23 .
or maternal allele IBD is only 0.082. We define the legacy coefficient of an individual as the probability that the paternal or maternal haplotype is transmitted to at least one typed child or grandchild. For example, the legacy coefficient is 0.5 if exactly one child of the proband is chip-typed, and 0.25 if exactly one grandchild is typed (Supplementary Note). The legacy coefficient, with some discount, should be about the probability that the paternal or maternal haplotype of an untyped proband can be imputed. In practice, haplotype imputation is done in two steps. The first step involves using LRP to simultaneously phase typed individuals and to identify haplotypes that are IBD. The second step overlays this information on the pedigree. On the basis of how individuals sharing a haplotype IBD are related, it can then be inferred that some untyped individuals must also carry the haplotype. The following example (Fig. 5) highlights how the second step works. The proband (P) is a deceased individual with lung cancer. One of his children (C1) and 10 of his grandchildren (GC1 to GC10) are chip-typed. His legacy coefficient is 0.89. Here we focus on a region around the nicotinic acetylcholine receptor gene cluster (CHRNA5, CHRNA3 and CHRNB4) on 15q25 where variants, including allele T of SNP rs1051730, were recently shown to associate with smoking behavior, lung cancer and peripheral arterial disease [17] [18] [19] [20] . As detailed in the figure legend, there are many sources of information from the pedigree that allowed us to impute H A and H B , two phased haplotypes composed of 1,001 consecutive SNPs centered at rs1051730, into P. In particular, we know that P is homozygous TT for rs1051730.
Given that C1 is typed, his children, GC1 and GC2, are not crucial for imputing P. However, as a proof of principle, suppose C1 is not typed. At this locus, because GC1 and GC2 carry H A and H C, respectively, they could be used to impute C1. The two haplotypes inferred this way agree completely with the actual genotypes of C1.
For untyped probands born after 1900, the average legacy coefficient is only 0.054, much less than the 0.176 of typed probands. This is because the untyped individuals are on average younger and there is some clustering in people chip-typed. Still, with 375,032 probands in this category, approximately 20,000 paternal and maternal haplotypes each could be imputed. For the 101,599 untyped individuals born between 1850 and 1900, the average legacy coefficient is 0.168. This corresponds to another 17,000 paternal and maternal haplotypes each. Another approximately 2,000 paternal and maternal haplotypes each could be deduced for individuals born before 1850. Overall, this corresponds to about 78,000 haplotypes being potentially imputable. The emphasis is on haplotypes instead of individuals because often only one haplotype of a person could be determined (for example, M1 in Fig. 5) . Also, although the 78,000 is an average number that applies to all locations in the genome with good coverage by the SNPs, who and which haplotype could be imputed vary from locus to locus. Finally, even when a haplotype was passed on to a typed child or grandchild, there are still instances in which the haplotype cannot be reliably imputed. We believe that the chance of this is around 10%.
DISCUSSION
We have demonstrated that when a substantial fraction of a population is genotyped with a high-density SNP array, there is much more information in the data than what lies on the surface. Compared to existing approaches that focus either on close relatives (family-based analyses) or on very distantly related ('unrelated') individuals (LD-based analyses), the conceptual leap here lies in the recognition of the utility of moderately to distantly related individuals, for example, those separated by 3 to 20 or more meioses. As the number of meioses increases, the decrease in the probability of IBD sharing for any particular relative is compensated for by the exponential increase in the number of such relatives. Although it is generally recognized among investigators familiar with linkage analysis that IBD sharing can often be detected without precise knowledge of the pedigree structure, it still came as a surprise when we realized that the information could be exploited in this systematic and extensive manner. Figure 5 Imputing haplotypes into an untyped proband P. One of his children (C1) and ten of his grandchildren (GC1 to GC10) are chip-typed (in blue). A region on 15q25 with 1,001 typed SNPs (every one-hundredth SNP is shown) centered at rs1051730 ( * ) was investigated. All typed individuals were phased, although only three haplotypes, H A , H B and H C , are highlighted. Haplotype H A could be imputed into P because C1 and GC10, descendants of P with different mates, share H A IBD, satisfying the first and third conditions for ensuring that the path of IBD sharing goes through the proband (see main text). R2 shares H B IBD with GC3 and GC4, satisfying the first and second conditions and allowing us to impute H B into P. However, as an exception to the second and third conditions, H B can actually be imputed into P in an alternative way that does not require R2 and only employs the data from the descendants. Given that GC3 and GC4 share H B , it must be carried by either P or M1, and the same with H C, as it is shared by C1 and GC6. Given that GC4 and GC6 are related to P and M1 in the same way, H B and H C cannot both originate from M1. As C1 has both H A and H C , and H A is established to be from P, H C must be from M1. This highlights that there could be extra information in addition to what can be deduced from the pairwise sharing of relatives. Because P is related to R1 on his father's side and R2 on his mother's side, we can deduce that H A is the paternal haplotype of P and H B is the maternal haplotype, information useful for an imprinting model. Although GC5, GC7, GC8 and GC9 do not play a role in the imputation of P here, they do contribute to the imputation of P for other regions in the genome. If C1 was not genotyped, GC1 and GC2 could be used to impute C1 and P.
To utilize the data fully, statistical methods need to be developed on two fronts. Many obvious methodological refinements could increase yield and reduce error rates. Most importantly, even though this new method can be applied to tasks that were previously impossible, its power can be further enhanced by incorporating ideas behind existing methods. In our phasing examples, LRP on its own was performing very well, but for more difficult regions or with a smaller sample typed, local phasing, which in effect could generate more informative markers than bi-allelic ones, could assist in both phasing and the detection of IBD sharing of shorter regions. Apart from being the first procedure that can systematically impute haplotypes into completely untyped individuals, our method can also be used in conjunction with previous methods for the imputation of untyped variants into individuals with other markers typed 21, 22 . On another front, we emphasize that proper, and sometimes sophisticated, statistical methods are needed in situations where valid estimates and measures of statistical significance are required.
The method presented should be transferable to settings other than that in Iceland if certain conditions are met and with proper adjustments (Supplementary Note). Long-range phasing and IBD detection do not require explicit knowledge of the genealogy. However, the number of individuals genotyped has to be above a certain threshold. Although many factors play a role, we speculate that having as little as 1% of a population genotyped may be adequate for the method to yield useful results. This would still correspond to a very big sample size for a large population, but it may be attainable in less than a decade given the fast pace in technological advance. This could be achievable in the near future, or already achieved, for smaller populations, including isolated regions within a large country. Indeed, the results shown here are particularly relevant for the planning of biobanks. The genealogy plays an important role in the imputation of untyped individuals. Still, even without it, haplotypes could be imputed into a proband if the mate and at least one child are genotyped, with the other relatives used to assist in resolving phase uncertainties, for example, when both mate and child are heterozygous. With high-density SNP data, close relationships could often be detected and it may be possible to reconstruct small families. It remains to be seen, with further methodological development, whether information on the mitochondria, the sex chromosomes and knowledge of ancestries of the proband and mate could assist in haplotype imputation. Recently, as a consequence of the unprecedented success of case-control genome-wide association studies, family-based studies have faded into the background. The results presented here are a reminder of the fact that genetics is ultimately a study of inheritance. Familial relations always have an important role, sometimes in unexpected ways.
METHODS
Individuals selected for the phasing project. The genotypes of 35,528 persons were used in this study. These individuals are participants in a large number of ongoing genome-wide association studies being conducted in-house. All biological samples used in this study were obtained according to protocols approved by the Data Protection Commission of Iceland and the National Bioethics Committee of Iceland. Informed consent was obtained from all participants and all personal identifiers were encrypted with a code that is held by the Data Protection Commission of Iceland. Four different Illumina chipbased arrays were used over the course of data collection, with a common core of over 300,000 SNPs. Respectively, 15,905, 6,740, 12,338 and 545 individuals were genotyped using the HumanHAP300, the HumanHAP300-Duo, the HumanCNV370-Quad and a precursor to the HumanHAP300 BeadChips. For inclusion in the study, the genotype yield of a person on that person's chip had to exceed 98% (1,561 individuals were excluded because of this criterion).
SNPs selected for phasing. A total of 290,449 SNPs were used for this phasing study. Each SNP had a genotyping yield greater than 95% on all four different chip types that were used to generate the genotypes and a Hardy-Weinberg statistic within and across chip types that was not significant at the P ¼ 0.0001 level. A few additional markers were excluded because they were monomorphic or had allele frequencies that varied by over 2% across the chip types. In all, 6.5% (n ¼ 20,220) of the 310,669 SNPs that were common to all the chip types were excluded from the study.
Identifying individuals with a deletion. The microdeletion at 15q11.2 was identified in the course of a study of the association of copy number variations (CNV) with schizophrenia. An Icelandic population-based sample of 2,160 trios and 5,558 parent-offspring pairs who had been genotyped on one of the Illumina chips was used to identify de novo deletion and duplication regions using dose (a probe-based intensity measure) and for analysis of loss of heterozygosity. The 15q11.2 deletion region was one of the 66 regions identified and subsequently investigated for association. In Iceland, 4 out of 646 individuals with schizophrenia and 58 out of 32,442 controls were shown to carry the deletion. In addition, one parent of an individual with schizophrenia also carried the deletion. Each of the 63 persons with a deletion in this region met the criteria for inclusion in this phasing study.
General principles behind long-range phasing. For a proband A, (putative) surrogate parents are identified on the basis of IBS sharing. Ideally, the surrogate parents can be separated into two groups, which correspond to surrogate fathers and surrogate mothers. However, determining which group is which is not necessary for the purpose of phasing. Group 1 shares haplotype H1 with the proband and Group 2 shares H2. For a SNP that is heterozygous in A, phase is determined if at least one of the surrogate parents is homozygous. For example, if a surrogate parent in Group 1 is homozygous for the major allele, then H1 has the major allele and H2 has the minor allele. Consider a SNP that is heterozygous in A and all of his surrogate parents. Its phase can still be determined as long as one of the surrogate relatives with Erdös distance higher than 1 is homozygous. For example, let B be a member of Group 1 and, apart from H1, let H3 be the other haplotype she carries. Treating B as the proband, one group of her surrogate parents includes everyone in Group 1 but her plus A, and the other group includes individuals carrying H3. Suppose a member of this latter group is homozygous for the major allele; this would imply that H3 has the major allele, which in turn implies that H1 has the minor allele. In general, consider a SNP that is heterozygous (1,2) in A and all of his surrogate relatives with a Erdös distance of K or less. If a surrogate relative C with Erdös distance K+1 is homozygous (1,1), then the haplotype of A through which she is linked to C by the shortest path has allele 2 if K is odd, and allele 1 if K is even.
Incompatibilities and error detection. If the putative surrogate parents identified for a proband are true, it should be possible to classify them all as a single group (when only surrogate mothers or fathers exist) or to divide them into two groups. However, any attempt to group the surrogate parents could result in incompatibilities. Specifically, for a SNP that is heterozygous in the proband, an incompatibility occurs when two surrogate parents in the same group have different homozygous genotypes or if two surrogate parents in separate groups have the same homozygous genotype. Incompatibilities could also result from genotypes of more distant surrogate relatives. This happens when a surrogate parent is heterozygous, but data from her other surrogate relatives nonetheless suggest that the allele she shared with the proband has to be, say, the minor allele, which happens to be in contradiction with the data of the other surrogate parents. Indeed, the fact that any surrogate relative, regardless of Erdös distance, could contribute to the phasing of another surrogate relative also means that for individuals belonging to the main cluster in the haplotype-sharing graph, even a single genotyping error for one of the SNPs can often be detected because of resulting incompatibilities. Although this means that the data have extraordinary power to detect irregularities, the challenge is in the determination of what is the cause of an incompatibility. Incompatibilities could result from several possible situations. First, they may result from simple genotyping errors. Second, they may result from misinterpretation of the data owing to the presence of structural mutations such as deletions and duplications in some of the individuals. Although this could be considered as a form of genotyping error, these errors are systematic rather than random, and in some cases may affect the calling of a long sequence of SNPs. Third, incompatibilities may result when a putative surrogate parent does not actually share a haplotype with the proband at the region at all or, more frequently, when the surrogate parent only shares a haplotype with the proband for part of the region (some recombination event has cut off the IBD sharing at a certain location, but by chance the IBS sharing continues).
With so many SNPs and individuals studied simultaneously, simple genotyping errors are unavoidable. Although practical phasing procedures will have to allow for some errors, the importance of high-quality genotypes cannot be overstated. On the basis of the 50 individuals who were typed twice, for individuals and SNPs that passed our quality-control criterion, we put the error rate at around 0.01% or lower, which is consistent with the discrepancies we observed for the trio test. Given proper treatment, isolated genotyping errors that influence SNPs individually do not pose a substantial problem. Regarding misinterpretation of data, the best approach is to identify the structural mutations in advance on the basis of extra information, such as that on probe intensities and SNPs, that is specifically designed to capture CNVs, with special attention paid to known locations harboring such variants. Our study of the deletion on 15q11.2 is one such example. There, we carried out phasing in two ways, with and without SNPs in the deletion region (Supplementary Note). The influence of the third cause of incompatibilities is discussed below, using the MHC region as an example.
The current phasing algorithm and the phasing of the 10-Mb MHC region. We carried out LRP in two rounds of three steps each. At round 1, step 1 identified putative surrogate parents for each proband. To minimize the impact of the third cause of incompatibilities described above, we selected only those individuals who had IBS Z 1 for all 2,187 SNPs in the extended 14-Mb (10 cM) region. This increased the chance that a putative surrogate parent would actually share a haplotype IBD with the proband for the entire 10-Mb target region. Missing genotypes were treated as wild cards and considered to be consistent with sharing. Even though we plan to do that in the future, imputation was not attempted. At step 2, for each proband, surrogate parents were first checked for incompatibilities. We phased a proband at this step only if no incompatibilities were observed for any of the SNPs. Because genotypes phased at this step would contribute to the next phasing step, this ensured that only very high-quality results would be carried over. Note that at step 2, data of surrogate parents entered the processing of a proband as unphased. However, every surrogate parent was himself a proband. At step 3, surrogate parents carried with them the phasing information obtained from step 2. This in effect used surrogate relatives with Erdös distance 2. Probands who were partially phased at step 2 could now have more of their heterozygous genotypes phased. Most of the probands who were not phased at all before owing to incompatibilities were also phased here. With additional information provided by some of the putative surrogate parents who were now partially phased, a reasonable but ad hoc (that is, rule-based instead of model-based) procedure (Supplementary Note) was used to resolve the incompatibilities. Sometimes, for a proband successfully phased for most of the SNPs, an individual SNP could be declared unphasable because of incompatibilities that resulted from the genotypes of many surrogate parents. Often the cause could be a genotyping error in the proband. Nevertheless, genotype correction was not attempted. Note that probands were processed one at a time, but the updated information for one proband was not applied to the phasing of the others until the next step/iteration, and thus the ordering of the probands had no impact on the results. After each proband had been processed, step 3 was then repeated, and the successive iterations brought in information contributed by surrogate relatives with Erdös distance 3 and higher. Round 1 was completed when the results of the iterations stabilized. At step 1 of round 2, we carried out a review to identify surrogate parents who were part of multiple incompatibilities (Supplementary Note). They were then removed from the surrogate parent list (even their genotypes that did not lead to incompatibilities would no longer be used). Steps 2 and 3 were then repeated.
Note that as missing or possibly wrong genotypes were not imputed or corrected, the final phase result is fully compatible with the original genotyping information that entered the algorithm.
